Tuberous sclerosis complex-associated refractory seizures Clinical Trials
Conditions / Tuberous sclerosis complex-associated refractory seizures
Delta Trials tracks 1 clinical trial for Tuberous sclerosis complex-associated refractory seizures in its publicly accessible dataset. Among the listed trials, 0 open for participant enrollment and 1 trial have reached completion. This research is carried out at 94 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
1
Total Trials
0
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
94
Study Locations
Browse by location (94 total)
- Genova, Italy 1 trialAll trials in Genova, Italy
- Ioánnina, Greece 1 trialAll trials in Ioánnina, Greece
- Heeze, Netherlands 1 trialAll trials in Heeze, Netherlands
- Guadalajara, Mexico 1 trialAll trials in Guadalajara, Mexico
- London, United Kingdom 1 trialAll trials in London, United Kingdom
- İstanbul, Turkey (türkiye) 1 trialAll trials in İstanbul, Turkey (türkiye)
- Istanbul, Turkey (türkiye) 1 trialAll trials in Istanbul, Turkey (türkiye)
- Shizuoka, Japan 1 trialAll trials in Shizuoka, Japan
- Amiens, France 1 trialAll trials in Amiens, France
- Dallas, United States 1 trialAll trials in Dallas, United States
- Ghent, Belgium 1 trialAll trials in Ghent, Belgium
- Rotterdam, Netherlands 1 trialAll trials in Rotterdam, Netherlands
- Jette, Belgium 1 trialAll trials in Jette, Belgium
- Nyíregyháza, Hungary 1 trialAll trials in Nyíregyháza, Hungary
- Nyíregyháza, Hungary 1 trialAll trials in Nyíregyháza, Hungary
- Nyíregyháza, Hungary 1 trialAll trials in Nyíregyháza, Hungary
- Izumi, Japan 1 trialAll trials in Izumi, Japan
- Samara, Russia 1 trialAll trials in Samara, Russia
- Caba., Argentina 1 trialAll trials in Caba., Argentina
- Caba, Argentina 1 trialAll trials in Caba, Argentina